Jobs / United States / Glaxosmithkline LLC
ViiV Healthcare (GSK) Senior Director, Early Development Leader
Glaxosmithkline LLC · 🇺🇸 USA - North Carolina - Durham
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Glaxosmithkline LLC paid sponsored hires in similar roles2 certified filings for “Associate Director/Scientific Leader, PDI” (Molecular and Cellular Biologists) in MA: $157k–$157k, median $157k. Most were filed at wage level II (50%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Glaxosmithkline LLC
The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Glaxosmithkline LLC →
About the role
ViiV Healthcare is a global specialty HIV company, the only one that is 100% focused on researching and delivering new medicines for people living with, and at risk of, HIV. ViiV is highly mission-driven in our unrelenting commitment to being a trusted partner for all people living with and affected by HIV. Our aim is to think, act, and connect differently through a focus on education on and treatment for HIV. We go to extraordinary lengths to deliver the sorts of breakthroughs, both in treatments, care solutions and communities, that really count. We go beyond the boundaries of medicine by taking a holistic approach to HIV through developing and supporting sustainable community programs and improving access to care. We are fully committed to push through every challenge until HIV/AIDS is eradicated. ViiV has played a significant part in delivering breakthroughs that have turned HIV into a manageable health condition. We offer the largest portfolio of HIV medicines available anywhere, and we continue our work to cater for the widest possible range of needs in response to the HIV epidemic. We are aware of how much is at stake for those affected by HIV and we show up every day 100% committed to the patients. Our work culture is fast-paced, diverse, inclusive, competitive, and caring. But ViiV isn’t just somewhere to work – it’s a place to belong, an invitation to bring your very best, and a team full of impact-driven team members who are hungry to make a difference. While we have been improving lives of HIV patients for 30 years, this is an especially exciting time to be at ViiV, as we evaluate novel approaches to treatment and prevention that could further reduce the impact of HIV on individuals and communities. The Senior Director, Early Development Leader is responsible for leading a global multidisciplinary development team within R&D to deliver on all aspects of early drug development (Candidate Selection through completion of POC and all activities sufficient to allow initiation of Phase 2b) to agreed timelines. This role will be based out of Durham, NC or PA Locations (UP, FMC, and/or UM) or Branford, CT & is eligible for domestic relocation package. The role can also be based at our GSK HQ in London, UK. This role will provide YOU the opportunity to lead key activities to progress YOUR career. These responsibilities include some of the following: • Leads the multi-functional global Early Development Team (EDT) responsible for delivery of an asset to Phase 2b • Proactively direct medicine development strategy and plans for products from Candidate Selection through Proof of Concept/Commit to Medicine Development • Contributes to the development of the regional and global strategy for products • Interface with Senior Management, internal key stakeholders and external stakeholders to articulate and drive the Medicine Development Strategy • Interface with other key functions during the development program such as Commercial to ensure alignment on strategy and project delivery timelines • Manages prioritisation of asset’s development options to effectively manage the budget • Utilizes organizational channels, experience and influencing skills to facilitate successful project progression and effective issue resolution • Accountable for the creation and maintenance of a clear and detailed medicine development strategy. Is the focal point for the early development activities of an asset throughout the organization. • Accountable for the creation of an integrated asset development plan through leadership of the EDT on a multi-disciplinary and global level • Accountable for creation and maintenance of overall project budget. • Responsible for representing the EDT at milestone and other key internal reviews at governan